Goldman Sachs

Baring Private Equity Asia is seeking a $265m loan to support its acquisition of India’s CitiusTech.

High grade dollar bond investors are braced for the biggest deal of the year after AbbVie, the pharmaceutical company, appointed a trio of banks to lead a possible $25bn issue that could come as soon as Monday.

Colgate Palmolive and Boston Scientific Corp printed €1.9bn of bonds this week, the latest US companies in the line to issue euro debt.

Technology firm Apple issued its first euro green bond on Thursday, selling a €2bn deal that bankers thought had been priced flat to its curve. The issue continued a strong recent run of Reverse Yankee deals.

Boston Scientific Corp, the US medical devices maker, obtained plenty of demand for its €900m bond as it made its debut in the Reverse Yankee market on Wednesday, while the euro corporate bond pipeline continues to fill for a flurry of issuance in November.

Oil major Royal Dutch Shell hit the euro bond market on Tuesday with a three-tranche trade that had an eight year tranche as its shortest maturity, Syndicate bankers say European Central Bank bond buying is creating more demand further out along the maturity curve.

State-owned China Petrochemical Corp (Sinopec) raised $2bn from three dollar bonds on Monday, making a rapid comeback to the debt market.

Six Chinese real estate issuers — mostly high yield — flooded the dollar bond market on Monday with one to four year tenor deals. Investment grade rated China Vanke Co, on the other hand, tapped the longer end of the curve with a dual-tranche issuance.

The US’s Colgate Palmolive brought a €1bn dual tranche bond on Monday, in a deal that bankers reckon is the 'tip of the iceberg' of euro issuance this week.

Pharmaron Beijing Co, a Chinese pharmaceutical research and development service platform, started testing investor appetite for its IPO on Monday.

The $166.3m loan to support Blackstone Group’s Essel Propack acquisition has been oversubscribed, with 10 participants joining during general syndication.

Cerberus Capital Management has sold more than half of its stake in Bawag, the Austrian banking group, via an accelerated bookbuild.